XRCC1 Arg280His polymorphism and glioma risk: A meta-analysis involving 1439 cases and 2564 controls

Pakistan Journal of Medical Sciences

Volumn 29, Issue 1, 2013, Pages

  Zhang, Liang ^a   Wang, Yan ^a   Qiu, Zhiqun ^a   Luo, Jiaohua ^a   Zhou, Ziyuan ^a   Shu, Weiqun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Malignancy; Meta analysis; Polymorphism; Susceptibility; XRCC1 Arg280His

Indexed keywords

ARGININE; HISTAMINE;

ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; ETHNIC DIFFERENCE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLIOMA; HOMOZYGOTE; HUMAN; X RAY REPAIR CROSS COMPLEMENTING GENE 1;

EID: 84868355633     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prasad G, Haas-Kogan DA. Radiation-induced gliomas. Expert Rev Neurother. 2009;9(10):1511-1517.
2. Montelli Tde C, Peracoli MT, Rogatto SR, Kaneno R, do Prado CH, Rocha Pde M. Genetic and modifying factors that determine the risk of brain tumors. Cent Nerv Syst Agents Med Chem. 2011;11(1):8-30.
3. Li GM. A special issue on DNA damage response and genome stability. Cell Biosci. 2012;2(1):4.
4. Blaisdell JO, Harrison L, Wallace SS. Base excision repair processing of radiation-induced clustered DNA lesions. Radiat Prot Dosimetry. 2001;97(1):25-31.
5. Ginsberg G, Angle K, Guyton K, Sonawane B. Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment. Mutat Res. 2011;727(1-2):1-15.
6. Munafo MR, Clark TG, Flint J. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res. 2004;129(1):39-44.
7. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
8. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1513-1530.
9. Kiuru A, Lindholm C, Heinavaara S, Ilus T, Jokinen P, Haapasalo H, et al. XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol. 2008;88(2):135-142.
10. Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffer JS, et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol. 2010;12(1):37-48.
11. Zhou LQ, Ma Z, Shi XF, Yin XL, Huang KX, Jiu ZS, et al. Polymorphisms of DNA repair gene XRCC1 and risk of glioma: a case-control study in Southern China. Asian Pac J Cancer Prev. 2011;12(10):2547-2550.
12. Hu XB, Feng Z, Fan YC, Xiong ZY, Huang QW. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to glioma. Asian Pac J Cancer Prev. 2011;12(11):2981-2984.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
14. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Techn Bull. 1999;8:15-17.
15. Curry WT Jr., Barker FG, 2nd. Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol. 2009;93(1):25-39.